PropertyValue
?:abstract
  • The cause and treatment of refractory hyperglycemia in a critically ill coronavirus disease 2019 (COVID-19) patient during treatment were analyzed retrospectively, indicating that novel coronavirus infection may cause damage to glucose metabolism, so the monitoring and control of blood glucose should be strengthened in clinical treatment Copyright © 2020 by the Chinese Medical Association
is ?:annotates of
?:creator
?:journal
  • Chinese_Journal_of_Endocrinology_and_Metabolism
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Reflections on the management of a coronavirus disease 2019 patient with refractory hyperglycemia
?:type
?:who_covidence_id
  • #831373
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/71csci0k>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/71csci0k>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all